Quantum Biopharma Ltd.

QNTM Healthcare Biotechnology

In the quarter to June 2026, EPS grew 85.5% and free cash flow grew 5.88%, each against the same quarter a year earlier.

2.47 0.24 −8.86%
Market cap
$21.9M
P/E
0.0×
Fwd P/E
−0.6×
Dividend yield
—
F-score
n/a
Altman Z
−0.26
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — —
EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
1.41 1.07 0.63 1.20
Net Debt/EBITDA
1.39 2.04 3.53 4.50
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.22) (0.13) (1.02) (0.47)
Book value per Share
1.97 1.55 (0.32) 0.92
Free Cash Flow
(0.85) (0.41) (4.56) (3.12)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates